Legend Biotech (LEGN) Other Accumulated Expenses (2019 - 2025)

Legend Biotech has reported Other Accumulated Expenses for 7 years, with the latest figure at $1.0 million in Q4 2025.

• For the quarter ending Q4 2025, Other Accumulated Expenses rose 100.0% year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2025 stood at $1.0 million (up 100.0% YoY), and the FY2025 full-year result was $1.0 million, up 100.0% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $1.0 million, roughly flat from $1.0 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $184.1 million in Q4 2022, with the low at $80096.0 in Q1 2021.
• Historically, Other Accumulated Expenses has averaged $106.0 million across 5 years, with a median of $122.9 million in 2021.
• Annual changes were most pronounced in 2021 — Other Accumulated Expenses soared 180579.81% — and 2024, when it plunged 99.59%.
• Legend Biotech's Other Accumulated Expenses stood at $123.6 million in 2021, then surged by 49.01% to $184.1 million in 2022, then plunged by 33.57% to $122.3 million in 2023, then sank by 99.59% to $500000.0 in 2024, then surged by 100.0% to $1.0 million in 2025.
• The last three Other Accumulated Expenses figures came in at $1.0 million (Q4 2025), $1.0 million (Q3 2025), and $138.8 million (Q2 2025), per Business Quant data.